Other languages Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Delayed OTC Markets Other stock markets 02:14:52 2024-05-13 pm EDT			5-day change	1st Jan Change
0.38 ^USD	+1.20%		-8.37%	-80.51%

Mar. 28	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28	Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28
Top Premarket Gainers	Feb. 22
Agile Therapeutics, Inc. Provides Revenue Guidance for the Full Year Ended December 31, 2023	Feb. 15
Agile Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Agile Therapeutics, Inc. Reaffirms Revenue Guidance for the Full Year 2023	Nov. 09
Agile Therapeutics, Inc. Affirms Revenue Guidance for the Year 2023	23-08-09
Agile Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Agile Therapeutics, Inc. Provides Revenue Guidance for the Year 2023	23-06-30
Agile Therapeutics, Inc. Announces Executive Changes	23-06-27
Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health	23-06-15
Agile Therapeutics, Inc. Announces New Agreement with vitaCare Prescription Services to Improve Access to Twirla	23-06-13
Agile Therapeutics Closes $7.5 Million Public Offering	23-05-26
Agile Therapeutics Prices $7.5 Million Public Offering of Common Stock, Warrants	23-05-23
Agile Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Agile Therapeutics, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2023	23-05-11
Agile Therapeutics, Inc. Provides Revenue Guidance for the First Quarter 2023	23-04-28
Agile Therapeutics Gets Board Approval for 1-For-50 Reverse Stock Split	23-04-10
MÄRKTE USA/Wall Street erholt sich von Fed-Dämpfer leicht	23-03-23
MÄRKTE USA/Wall Street vor leichter Erholung nach Fed	23-03-23
Agile Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Other languages

Filters